New funding opportunities for members SeptemberSeptember 8, 2020
We try to make this as relevant to you as possible so please let us know if there is anything we have missed that you feel should be included.
Covid-19 Specific Funding
Global Effort on Covid-19 (GECO) Health Research. Deadline: 28 September 2020
Global Effort on Covid-19 (GECO) Health Research is a new cross UK government funding call aiming to support applied health research that will address Covid-19 knowledge gaps. The focus is on understanding the pandemic and mitigating its health impacts in low and middle-income countries (LMIC). The call prioritises epidemiology, clinical management, infection control and health system responses.
UKRI open call for research and innovation ideas to address Covid-19. There is no closing date
UK Research and Innovation (UKRI) will support excellent proposals of up to 18 months duration which meet at least one of the following: a) New research or innovation with a clear impact pathway that has the potential (within the period of the award) to deliver a significant contribution to the understanding of, and response to, the Covid-19 pandemic and its impacts. b) Supports the manufacture and/or wide scale adoption of an intervention with significant potential. c) Gathers critical data and resources quickly for future research use.
National Institute for Health Research: Travel and subsistence funding to support LMIC engagement during the Covid-19 outbreak. Deadline 31 December 2020
The awards will provide travel and subsistence funding to appropriately qualified public health professionals, clinicians and academics who wish to offer science and technical advice to support the immediate response to Covid-19 in low and middle-income countries. The awards are open to applicants who have a substantive position at a UK higher education institution or research organisation.
Fast Funding for Covid-19 Science. Deadline: 31 December 2020.
A new venture fund is offering grants of $10,000 to $500,000 to coronavirus researchers, and every grant decision will be made in less than 48 hours.
New Future Fund To Support Innovative UK Businesses
The Chancellor of the Exchequer today announced he is to establish a new Future Fund to support the UK’s innovative businesses currently affected by Covid-19. These businesses have been unable to access other government business support programmes, such as CBILS, because they are either pre-revenue or pre-profit and typically rely on equity investment. The scheme will deliver an initial commitment of £250m of new government funding which will be unlocked by private investment on a match-funded basis. The government scheme, which will be developed in partnership with the British Business Bank with the intention of launching for applications in May, will initially be open until the end of September. Over the coming weeks, the Bank will work with the government on the details on how the Future Fund will operate and how to apply for the scheme.
Bill & Melinda Gates Foundation, Wellcome & Mastercard Covid-19 Therapeutics Accelerator.
The Bill & Melinda Gates Foundation, Wellcome, and Mastercard have committed up to $125 million in seed funding to speed-up the response to the Covid-19 epidemic by identifying, assessing, developing, and scaling-up treatments. The partners are committed to equitable access, including making products available and affordable in low-resource settings. The Covid-19 Therapeutics Accelerator will play a catalytic role by accelerating and evaluating new and repurposed drugs and biologics to treat patients with Covid-19 in the immediate term, and other viral pathogens in the longer-term. Currently, there are no broad-spectrum antivirals or immunotherapies available for the fight against emerging pathogens, and none approved for use on Covid-19.
Covid-19 – Other International Funding (and more) read KTN round-up
Covid-19 – Support for Businesses – for the latest information on UK Govt support available.
Other Featured Funding
i4i Connect call. Deadline: 16 September 2020
The NIHR Invention for Innovation (i4i) Programme is delighted to launch its fourth round of i4i Connect Call – aimed at small and medium-sized med-tech enterprises (SMEs) in need of a funding boost to reach their next stage in the development pathway and accelerate the development of promising medical technologies.
Innovate UK Smart Grants: August 2020. Deadline: 25 November 2020
Opportunity for UK registered organisations to apply for a share of up to £25 million from Innovate UK to deliver disruptive R&D innovations that can significantly impact the UK economy.
Other Funding Opportunities
EUREKA GlobalStars Japan. Deadline: 10 September 2020
Open call (although pharmaceutical projects not in scope): UK registered businesses can apply for a share of up to £1 million to develop innovative proposals with Japan and other EUREKA participating members.
Using digital technology to support psychological therapies (SBRI). Deadline: 16 September 2020.
Organisations can apply for a share of up to £345,000 (including VAT) to develop new solutions using digital technology to provide psychological support.
Designing sustainable plastic solutions. Deadline: 16 September 2020
Competition to win funding for early-stage, human-centred design projects to reduce plastics’ harm to the environment, increase productivity and grow the UK economy.
Biomedical Catalyst 2020: round 1, early and late stage awards. Deadline: 7 October 2020
UK registered SMEs can apply for a share of up to £30 million to develop a product or process that is an innovative solution to a health and care challenge.
EUREKA GlobalStars Singapore CRD – Round 2. Deadline: 15 October 2020
Open call: UK registered businesses can apply for a share of up to £1 million to develop innovative proposals with Singapore and other EUREKA participating members.
For more information on all open IUK funding opportunities
Defence and Security Accelerator (DASA)
Open Competition: rolling deadline.
The Open Call is one of the funding competition mechanisms DASA uses to find proposals that address challenges faced by government stakeholders. It gives bidders the opportunity to present their ideas to defence and security stakeholders at any time, without waiting for a relevant Themed Competition.
National Institute for Health Research (NIHR)
NIHR Artificial Intelligence for Multiple LTC (AIM) (Finalised). Deadline: 29 September 2020
The National Institute for Health Research (NIHR) invites proposals to undertake programmes of research to spearhead the use of artificial intelligence (AI) methods to develop insights for the identification and subsequent prevention of multiple long-term conditions (multimorbidity) or MLTC-M.
ECONOMIC AND SOCIAL RESEARCH COUNCIL (ESRC): Research Grants. Deadline: Open call.
If you have an excellent idea for a research project, the EPSRC have their Research Grants open call. Awards ranging from £350,000 to £1 million (100 per cent full Economic Cost (fEC)) can be made to eligible institutions to enable individuals or research teams to undertake anything from a standard research project through to a large-scale survey and other infrastructure or methodological development.
ENGINEERING AND PHYSICAL SCIENCES RESEARCH COUNCIL (EPSRC):
The EPSRC is the main funding body for engineering and physical research sciences. For EPSRC funding opportunities.
MEDICAL RESEARCH COUNCIL (MRC)
The Medical Research Council (MRC) improves the health of people in the UK – and around the world – by supporting excellent science, and training the very best scientists.
Click here for more MRC funding opportunities
Trust and Charities
Association of Medical Research Charities
Over 30 years ago a small, diverse group of medical research charities form the Association of Medical Research Charities (AMRC) to unite the sector and provide it with a leading voice. Since then their membership has grown to over 140 charities. In 2018, these charities invested £1.3 billion in medical research. Click to access their database.
Other UK Government, Seed Funds and Loans
THE BRITISH BUSINESS BANK: Deadline: Open.
BBB are a government-owned business development bank dedicated to making finance markets work better for smaller businesses. Whether you’re looking for finance to start a business, grow to the next level, or stay ahead of the competition, they say that they can deliver greater volume and choice of finance.
Small Business Research Initiative (SBRI) funding. General ‘collection’ of news and funds.
Information about SBRI for businesses and public sector organisations that might want to use the scheme.
UK Innovation & Science Seed Fund. Open.
The UK Innovation & Science Seed Fund (formerly known as The Rainbow Seed Fund) is a £27.1m early-stage venture capital fund building and growing technology companies stemming from the UK’s research base.
Creative England Investments. Deadline: open.
Creative England is supporting SMEs by providing competitive loans to digital businesses in order to make their growth plans a reality. The investments on offer are intended to fuel this fast-growing sector by financing business expansion and new products, leading to the creation of new high-quality jobs and Intellectual Property (IP). Loans from £50,000 – £250,000 are available with repayment terms ranging from 3-36 months. Interest rates range from 5% – 10%, depending on the risk profile of the applicant. This includes companies from within the digital healthcare sector.
HSBC Loan Fund. Open.
HSBC UK has announced a £12 billion lending fund to support the UK’s small and medium-sized enterprises (SMEs). The Fund includes a ring-fenced £1 billion to help UK companies grow their business overseas, as well as a broader package of support. The initiative is available to UK businesses with a turnover of up to £350 million. Applicants do not need to be an HSBC customer to apply.
Export Opportunities – To access the Department of International Trades Export Opportunities Pipeline
Deliver safer and better care for people in Scotland with diabetes, phase 1 (SBRI competition)
NHS Scotland is investing up to £300,000 including VAT, in innovative solutions in 3 challenge areas as follows:
- Using artificial intelligence and machine learning to help develop prediction algorithms and risk stratification for diabetes foot ulceration, amputations and mortality.
- Improving the clinical care of patients with a pre-existing diagnosis of diabetes when admitted to hospital by developing a real-time decision support tool and alert mechanism. The tool must improve triage, prevent medication errors, identify emergencies and streamline the diabetes care pathway.
- Improving the identification (case finding) of people at risk of osteoporosis and fracture, including those with diabetes.
Closing date for applications: 23 September 2020. For more details of the funding
Q Exchange, will this year focus on one theme: embedding positive changes emerging through new collaborations or partnerships during Covid-19. We will offer 20 awards, of up to £30k each, to support Q members to develop and embed promising and positive changes. Application open from 1 September 2020.
KTN: Latest Health and Life Sciences Funding Round-Up